Diagnostic Robotics announced recently that it closed a $45 million Series B funding round.
The artificial intelligence (AI) and care management solution developer had its Series B round led by StageOne investors. Mayo Clinic also participated, making the Israel-based firm a Mayo Clinic portfolio company.
According to a news release, Technion — Israel Institute of Technology and other existing investors also participated, along with strategic angel investor Bradley Bloom, the co-founder of Berkshire Partners.
Diagnostic Robotics said that it plans to accelerate its product development and its go-to-market growth, with planned investment in sales and marketing, plus other key hires across the organization. The company said its already experienced significant growth over the course of this year, tripling its revenues year-over-year since 2020.
“Diagnostic Robotics is using the most precise predictive models, leveraging nuanced definitions of r…